|
|
 |
|
Viewing report
|
|
 |
 |
Singapore Phamaceuticals & Healthcare Report Q1 2008
Business Monitor International, Feb 2008, Pages: 68
Executive Summary Singapore Pharmaceuticals and Healthcare Industry SWOT Singapore Political SWOT Singapore Economic SWOT Singapore Business Environment SWOT Pharmaceutical Business Environment Ratings
Pharmaceutical Ratings - Revised Methodology Ratings Overview Table: Pharmaceutical Business Environment Indicators Weighting Table: Weighting Of Components Singapore - Business Environment Ranking Table: Asia Pacific Pharmaceutical Business Environment Ratings Limits of Potential Returns Risks to Realisation of Returns
Singapore - Market Summary Regulatory Regime Recent Regulatory Developments Intellectual Property Issues Pricing and Reimbursement
Industry Trends and Developments Healthcare Sector Healthcare Company Developments Healthcare Insurance Developments Epidemiology Table: Principal Causes of Death in Singapore (% of total deaths)
Pharmacy Sector Domestic Pharmaceutical Sector Foreign Industry Foreign Company Activities Research and Development Biotechnology Recent Research and Development Activities Clinical Trials
Industry Forecast Sce30 Overall Market Forecast Table: Singapore’s Drug Market Forecast Indicators Key Growth Factors - Industry Table: Singapore’s Health Expenditure Forecast Indicator Key Growth Factors - Macroeconomic Table: Singapore - Economic Activity Prescription Market Forecast Table: Singapore Prescription Drug Market Forecast Indicators (US$mn unless otherwise stated) OTC Market Forecast Singapore Pharmaceuticals & Healthcare Report Q1 2008 Table: Singapore OTC Market Forecast Indicators (US$mn unless otherwise stated) Generics and Patented Drug Market Forecast Table: Singapore Generics and Patented Market Forecast Indicators Export/Import Forecasts Table: Singapore Import and Export Forecast Indicators (US$mn)
Other Healthcare Data Forecasts Table: Hospital And Population Data Trends Key Risks To our Forecast Scenario Competitive Landscape Table: Singapore Pharmaceutical Market, 2006
Company Profiles Leading Multinationals Pfizer GlaxoSmithKline Merck & Co Novartis Sanofi-Aventis Baxter
Indigenous Manufacturers Haw Par Corporation Ltd SciGen Ltd MerLion Pharmaceuticals Veredus Laboratories
BMI Forecast Modelling How We Generate Our Industry Forecasts Pharmaceutical Industry Sources
Customers who bought this item also bought
Singapore Pharmaceuticals and Healthcare Report Q4 2009
Executive Report on Strategies in Singapore
Singapore Pharmaceuticals and Healthcare Report Q3 2008
Telecommunications in Singapore
The Medical Device Market: Singapore
Snapshots Singapore Hotels 2007
Foodservice in Singapore
The Pharmaceutical Market: Singapore
Singapore Tourism Report Q4 2009
Medical Tourism Market in Asia: Focus on Thailand, Malaysia, Singapore & India
Tomorrow's Singapore
Singapore Tourism Report Q3 2009
|
 |
|
|